10 Bill Miller Karuna Therapeutics Trades
The first Karuna Therapeutics trade was made in Q1 2021. Since then Bill Miller bought shares four more times and sold shares on five occasions. The investor sold all their shares in Q2 2023 and doesn't own any shares in Karuna Therapeutics anymore.
Avg closing price
Price range
Sold -165 Thousand shares
Q2 2023
Avg closing price
$214.25
Price range
$176.32
-
$240.22
Increased shares by 13.8% (+20 Thousand shares)
Q1 2023
Avg closing price
$191.25
Price range
$161.33
-
$204.36
Sold 14.9% shares (-25.4 Thousand shares)
Q4 2022
Avg closing price
$214.43
Price range
$191.53
-
$236.82
Sold 23.6% shares (-52.6 Thousand shares)
Q3 2022
Avg closing price
$202.40
Price range
$123.79
-
$277.42
Sold 7.8% shares (-18.9 Thousand shares)
Q2 2022
Avg closing price
$114.93
Price range
$93.97
-
$143.33
Increased shares by 0.2% (+525 shares)
Q1 2022
Avg closing price
$112.59
Price range
$98.90
-
$132.37
Increased shares by 0.8% (+1.9 Thousand shares)
Q4 2021
Avg closing price
$129.25
Price range
$110.64
-
$159.40
Sold 19.5% shares (-57.9 Thousand shares)
Q3 2021
Avg closing price
$115.44
Price range
$101.20
-
$125.87
Increased shares by 2.1% (+6.05 Thousand shares)
Q2 2021
Avg closing price
$116.89
Price range
$107.45
-
$135.95
New holding (+291 Thousand shares)
Q1 2021
Avg closing price
$113.29
Price range
$95.46
-
$133.08
News about Karuna Therapeutics Inc and Bill Miller
Karuna Therapeutics to Present at the 2022 RBC Capital Markets Global Healthcare Conference
BOSTON--(BUSINESS WIRE)---- $KRTX--Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transfor...
Miller Value Partners LLC Has $33.89 Million Stock Position in Karuna Therapeutics, Inc. (NASDAQ:KRTX)
Miller Value Partners LLC grew its stake in shares of Karuna Therapeutics, Inc. (NASDAQ:KRTX) by 2.1% during the 2nd quarter, Holdings Channel.com reports. T...
Karuna Therapeutics Inc (KRTX) COO Andrew Craig Miller Sold $987,135 of Shares
Related Stocks: KRTX ,